The risk of musculoskeletal adverse outcomes after treatment with endocrine blocking treatments for breast cancer (MSKAI)First published 09/12/2020 Last updated 22/02/2024 EU PAS number: EUPAS38362StudyOngoing
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of OxfordUnited Kingdom First published: 01/02/2024Last updated 01/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facility
IQVIAUnited Kingdom First published: 12/11/2021Last updated 22/04/2024 InstitutionNon-Pharmaceutical companyENCePP partner
Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAPJGolSpain First published: 05/10/2012Last updated 23/02/2024 InstitutionEducational InstitutionLaboratory/Research/Testing facilityNot-for-profitENCePP partner
Observational Health Data Sciences and Informatics (OHDSI) Network First published: 01/02/2024Last updated 01/02/2024 Network
European Health Data Evidence Network (EHDEN)Netherlands First published: 01/02/2024Last updated 11/06/2024 Network